NextCure, Inc.
Pharmaceutical company · Baltimore, Maryland, United States · Nasdaq: NXTC
NextCure, Inc. is a pharmaceutical company headquartered in Baltimore, Maryland, United States. Its earliest recorded incorporation is in 2015. Its shares trade on Nasdaq under the ticker NXTC. It has reported private securities offerings to the US SEC, most recently $22 million sold in a notice filed in 2025.
NextCure at a glance
What does NextCure do?
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $21.5 million sold (2025).
Frequently asked questions about NextCure
Where is NextCure headquartered?
NextCure, Inc. is headquartered in Baltimore, Maryland, United States.
What does NextCure do?
NextCure, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is NextCure a public company?
Yes. NextCure, Inc. trades on Nasdaq under the ticker NXTC.
When was NextCure founded?
The earliest incorporation on record for NextCure, Inc. is in 2015, according to public company registers.
Similar companies
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
- Marker Therapeutics, Inc.Houston, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.